Menu
(If Available)
Nov. 26, 2024
Austin Argentieri, PhD
Research Fellow in Analytic and Translational Genetics Unit at Massachusetts General Hospital
Leveraging large-scale population biobank data to study aging and chronic age-related diseases
Nov. 7, 2024
Peter Tompa, PhD, Professor emeritus/VIB-VUB Center for Structural Biology, Brussels
Targeting biomolecular condensation: a new modality in drug development
September 26, 2024
Yingpu Yu, PhD
Research Associate, laboratory of Virology and Infectious disease, The Rockefeller University
An RNA-based system to study hepatitis B virus replication and evaluate antivirals
September 19, 2024
Mark Yorek, PhD
Professor of Medicine, University of Iowa & Associate Chief of Staff Iowa City VA Health Care System
From Bench to Bedside: Omega-3 Polyunsaturated Fatty Acids as a Potential Treatment for Diabetic Peripheral Neuropathy
September 18, 2024
Rui Liu, PhD
Research Assistant Professor, University of Notre Dame
Short Stories in the Medicinal Chemistry
August 15, 2024
Dr. Albert Jeltsch, PhD
Prof. of Biochemistry, University of Stuttgart, German
Analysis of the specificities of DNA and protein methyltransferases leading to novel insights into epigenetic processes
August 7, 2024
Dr. Llorente Bonoga, PhD
Senior Director, GRACS CMC
Enabling First in Human Studies: Regulatory Requirements, Regulatory Documentation and CMC Risks and Mitigations Part 2:
“Regulatory CMC Considerations for Clinical Studies”
July 25, 2024
Dr. Brett Tounge, PhD
Co-Founder and Managing Partner, Chairman at Mebias Discovery
The discovery and development of non-addictive analgesics utilizing Mebias’ novel drug discovery platform
June 13, 2024
Maarouf Hoteit, MD, AGAF.
Associate Professor of Clinical Medicine, University of Pennsylvania
May 30, 2024
Dr, Manisha Srivastava, PhD.
Associate Director, GRACS CMC
Enabling First in Human Studies: Regulatory Requirements, Regulatory Documentation and CMC Risks and Mitigations, Part 1: “Global CMC Documentation and CMC Strategies Enabling Global Phase 1 Studies”
May 16, 2024
Heather Finlay, PhD.
VP Medicinal Chemistry, Exelixis
April 25, 2024
Shihyun You, PhD.
Professor of Biochemistry, University of Stuttgart, German
April 11, 2024
Targeted Protein Degradation for Antiviral Drug Discovery
March 28, 2024
Distinguished Speaker Series
March 14, 2024
February 22, 2024
Dr. Theo Heller, MD
Senior Investigator NIH, Bethesda, MD
HDV: D is for Diabolical, or “Are we Winning Yet?”
January 11, 2024
Outstanding Young Scientist Series
December 19, 2023
November 16, 2023
Betacoronaviruses Optimize Replication by Balancing Antagonism of Innate Immune Responses and ER Stress Responses
November 3, 2023
October 26, 2023
September 7, 2023
Cristina Woo, PhD.
Department of Chemistry and Chemical Biology Harvard University
Sigma-2 and Alzheimer’s Disease: A therapeutic opportunity
Auguts 31, 2023
Patrick Glassman, PhD.
Assistant Professor of Pharmaceutical Sciences at Temple University School of Pharmacy
Drug Delivery Strategies in Acute Critical illness
July 27, 2023
Benjamin E Blass, PhD.
Department of Chemistry and Chemical Biology Harvard University
Sigma-2 and Alzheimer’s Disease: a Therapeutic Opportunity
July 13, 2023
July 6, 2023
Ertl Hildegund, MD.
Professor, Vaccine & Immunotherapy Center, The Wistar Institute
A therapeutic HBV vaccine containing a novel checkpoint modifier enhances and broadens CD8+ T cell responses which resulted in improved antiviral responses in preclinical studies
June 29, 2023
Jun Wan, PhD
Associate Professor, Medicinal Chemistry, Pharmacology and Chemical Biology Rutgers University
Nick Meanwell, PhD.
Drug design and pharmacology of SARS-CoV-2 main protease inhibitors
June 13, 2023
The Blurred lines of Chronic Hepatitis B
February 23, 2023
Inhibitors of HIV-1 Maturation: The Discovery of Fipravirimat
January 19, 2023
December 8, 2022
November 3, 2022
November 2, 2022
New humanized mouse models for HBV gene editing
October 11, 2022
Distinguished Speaker Series
June 23, 2022
Distinguished Speaker Series
June 9, 2022
April 1, 2022
The Long Road to an HBV Cure
March 31, 2022
March 24, 2022
Drew Weissman, MD, PhD.
Roberts Family Professor in Vaccine Research, University of Pennsylvania Perelman School of Medicine
Distinguished Speaker Series